EZM 2302
EZM 2302 is a potent and orally active CARM1 inhibitor with an IC50 value of 6 nM. EZM 2302 shows antiproliferative activity and anti-tumor activity. EZM 2302 inhibits PABP1 and SMB expression[1].
Product Specifications
CAS Number
[1628830-21-6]
UNSPSC
12352005
Hazard Statement
H302
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/EZM_2302.html
Purity
99.51
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CNC[C@@H](O)COC1=CC=C(Cl)C(C2=NC(N3CC4(CCN(C(OC)=O)CC4)C3)=C(C)C(C5=C(C)ON=C5C)=N2)=C1
Molecular Formula
C29H37ClN6O5
Molecular Weight
585.09
Precautions
H302
References & Citations
[1]Drew AE, et al. Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma. Sci Rep. 2017 Dec 21;7 (1) :17993.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PRMT4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7076811 Inquire
Recombinant Aspergillus oryzae Probable ubiquitination network signaling protein acrB (acrB), partial
Ask
View Details F0019-90 100 µL
Fatty Acid Binding Protein 7, Brain (B-FABP, BLBP, Brain lipid-binding protein, DKFZp547J2313, FABPB, Fatty acid-binding protein, brain, Fatty acid-binding protein 7, Mammary-derived growth inhibitor related, MRG)
Ask
View Details